Increased Percentage of CD8 <sup>+</sup> CD28 <sup>−</sup> Regulatory T Cells With Fingolimod Therapy in Multiple Sclerosis

Timothy W. Houston, Quentin Howlett-Prieto, Colin Regenauer, Fernando D. Testai, Faith Yao, Xuan Feng, Anthony T. Reder

Neurology Neuroimmunology & Neuroinflammation · 2022 · 10 citations · 36 references

DOIFull text

Open access

Concepts

Abstract

BACKGROUND AND OBJECTIVES: T-cell expression of the CD69 activation/lymph node retention protein in MS. METHODS: cells, was used to mimic inflammation. RESULTS: Treg population in therapy-naive MS, but only slightly altered Treg levels in fingolimod-treated MS. DISCUSSION: CTL in patients with MS; the loss is more pronounced in older patients with MS. This suggests that inflammation can disrupt the tenuous immune regulation in MS, especially in older patients.

References

36